Citations 11
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Logan, Brent R. , Nakamura, Ryotaro , Johnston, Laura, Choi, Sung Won , Pasquini, Marcelo C. , MacMillan, Margaret L. , Hsu, Jack W., Waller, Edmund K. , Wu, Juan , Hu, Zhen‐Huan , Carter, Shelly L., Horowitz, Mary M. , Antin, Joseph H. , Cutler, Corey S. , Porter, David , Hogan, William J. , Grupp, Stephan A. , McCarthy, Philip L. , Waller, Edmund K , Choi, Sung Won
Blood | July 1, 2014 | Volume: 124 | Issue: 8 | Pages: 1372-1377
Key Points Tac/Sir prophylaxis provides equivalent GVHD-free survival when compared with Tac/Mtx in MRD transplantation. Tac/Sir is associated with more rapid engraftment and reduced oropharyngeal mucositis after MRD transplantation.